Phase 2 Systemic Lupus Erythematosus, SLE trials recruiting now

All Systemic Lupus Erythematosus, SLE trials, every phase

Other phases for Systemic Lupus Erythematosus, SLE

Phase 2 Systemic Lupus Erythematosus, SLE trials

• A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
  NCT07328581 · Phase: Phase 2 · Ages: 16 Years to 70 Years · Sex: All (male and female) · 4 locations
• Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
  NCT06585514 · Phase: Phase 1, Phase 2 · Ages: 3 Years to 65 Years · Sex: All (male and female) · 1 location
• CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
  NCT06839976 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 29 Years · Sex: All (male and female) · 1 location
• Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
  NCT06032923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 120 Years · Sex: Female · 1 location
• Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
  NCT05688696 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 41 locations
• FT839 in Autoimmune Diseases
  NCT07800871 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
  NCT06675422 · Phase: Phase 1, Phase 2 · Ages: 14 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
  NCT07010835 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
  NCT07340463 · Phase: Phase 2 · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
  NCT07185269 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
  NCT07447986 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 40 locations
• Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
  NCT07041801 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.